Takeda Pharmaceutical EBIT Margin 2010-2024 | TAK

Takeda Pharmaceutical ebit margin for the quarter ending September 30, 2024 was 4.46%.

  • Takeda Pharmaceutical average ebit margin for 2023 was 10.21%, a 2.39% decline from 2022.
  • Takeda Pharmaceutical average ebit margin for 2022 was 10.46%, a 86.54% decline from 2021.
  • Takeda Pharmaceutical average ebit margin for 2021 was 77.73%, a 921.42% decline from 2020.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Takeda Pharmaceutical EBIT Margin 2010-2024 | TAK

  • Takeda Pharmaceutical average ebit margin for 2023 was 10.21%, a 2.39% decline from 2022.
  • Takeda Pharmaceutical average ebit margin for 2022 was 10.46%, a 86.54% decline from 2021.
  • Takeda Pharmaceutical average ebit margin for 2021 was 77.73%, a 921.42% decline from 2020.

Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues